Partner with us

In order to advance our innovative R&D pipeline we are continuously seeking new collaborations through licensing, partnering, R&D alliances or other collaborations with leading players in the industry who can effectively contribute to bring novel MLT-based products to the market and make them available to patients globally.


Lipopharma is currently prioritizing partnering opportunities for its lead R&D program with LP561A1 in oncology, which has just completed a PI/IIa trial with excellent results. We are open to discuss global partnering opportunities as well as potential collaborations with strong and motivated local development and commercial partners in specific markets like Japan, China, South Korea, Russia, Europe, Mexico or North America, were Lipopharma holds strong IP rights for this product.


We are also considering partnering and investing opportunities for other MLT-based products in our pipeline, and particularly for our promising LP226A1 program in AD

If you are interested in exploring partnering opportunities for some of our innovative R&D programs please contact us at This email address is being protected from spambots. You need JavaScript enabled to view it.

© 2019 Lipopharma Therapeutics. All rights reserved | legal notice

Ctra. de Valldemossa Km. 7,4. ParcBIT. Edifici Disset. 2n. Mod. C-8. E07121 - Palma de Mallorca. Spain  | Phone/Fax: +34 971439886  |  Email:

Login Form